Union Commerce Minister Piyush Goyal defended India's intellectual property rights during a press meeting with Swiss ...

The concept of evergreening refers to a strategy used by pharmaceutical companies to extend the life of patent protection beyond the term of one or more “original” patents. Companies often ...

Goyal positioned India's approach as protecting the rights of both innovators and consumers, arguing that companies should be able to recover their research and development investments during the ...

India's Commerce Minister refutes claims of Indian pharma firms copying products, highlighting India's respect for ...

Put simply, evergreening is when a pharma company patents minor modifications on the drug as “new inventions” and then uses the new patents to extend their monopoly, freezing out competition ...

India has offered to supply complex generics at just 20–25 percent of the branded drug prices for the first three years after ...

The government will impose tariffs on pharmaceutical companies if the prices in the ... broader patentability criteria, and evergreening practices. India has been resisting such patent ...